Recurrent Corneal and Conjunctival Dysplasia in an Immunocompromised Patient – The Interesting Case

Klin Monbl Augenheilkd 2022; 239(04): 390-392
DOI: 10.1055/a-1785-4320

Der interessante Fall

Rezidivierende Hornhaut- und Bindehautdysplasie bei einem immungeschwächten Patienten – der interessante Fall

Yasmine Derradji

Department of Ophthalmology, University Hospital Basel, Basel, Switzerland

,

Peter Meyer

Department of Ophthalmology, University Hospital Basel, Basel, Switzerland

,

Zisis Gatzioufas

Department of Ophthalmology, University Hospital Basel, Basel, Switzerland

References
1 Fraunfelder FT, Wingfield D. Therapy of intraepithelial epitheliomas and squamous cell carcinoma of the limbus. Trans Am Ophthalmol Soc 1980; 78: 290-300
2 Yang J, Foster CS. Squamous cell carcinoma of the conjunctiva. Int Ophthalmol Clin 1997; 37: 73-85
3 Gupta A, Muecke J. Treatment of ocular surface squamous neoplasia with Mitomycin C. Br J Ophthalmol 2010; 94: 555-558
4 Frucht-Pery J, Sugar J, Sutphin JE. et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology 1997; 104: 2085-2093
5 Frucht-Pery J, Rozenman Y, Peʼer J. Topical mitomycin-c for partially excised conjunctival squamous cell carcinoma. Ophthalmology 2002; 109: 548-552
6 Tabin G, Levin S, Snibson G. et al. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology 1997; 104: 485-492
7 Shields CL, Naseripour M, Shields JA. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol 2002; 133: 601-606